As HHS proposes updates to the HIPAA Security Rule, learn what HIM leaders must prioritize to stay ahead of compliance mandates and protect sensitive patient data.
CMS determined the improper payment rate for immunosuppressive drugs was 15.7% in 2023, with a projected improper payment amount of $43.2 million. Organizations should review CMS' guidance on proper billing codes, coverage criteria, common denial reasons, and documentation requirements.